Spots Global Cancer Trial Database for rubex
Every month we try and update this database with for rubex cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Molecular Triaging of Newly Diagnosed Breast Cancer | NCT01159236 | Breast Cancer | Paclitaxel Fluorouracil Doxorubicin Epirubicin Cyclophosphamid... Bevacizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease | NCT01404936 | Lymphoma | Interferon-2A Adriamycin Bleomycin Velban Dacarbazine | - | M.D. Anderson Cancer Center | |
| Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease | NCT01404936 | Lymphoma | Interferon-2A Adriamycin Bleomycin Velban Dacarbazine | - | M.D. Anderson Cancer Center | |
| Primary Breast Cancer Occurring Concomitant With Pregnancy | NCT00510367 | Breast Cancer Pregnancy | 5-Fluorouracil Cyclophosphamid... Doxorubicin | - | M.D. Anderson Cancer Center | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | NCT00147225 | Solid Tumors Advanced Cancer | AMG 531 Carboplatin Adriamycin Ifosfamide | 18 Years - | M.D. Anderson Cancer Center | |
| AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | NCT00147225 | Solid Tumors Advanced Cancer | AMG 531 Carboplatin Adriamycin Ifosfamide | 18 Years - | M.D. Anderson Cancer Center | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children | NCT03111069 | Malignant Neopl... Rhabdomyosarcom... Rhabdomyosarcom... | Abdominal Surge... Doxorubicin Intra-Operative... | 1 Year - 6 Years | M.D. Anderson Cancer Center | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | NCT00147225 | Solid Tumors Advanced Cancer | AMG 531 Carboplatin Adriamycin Ifosfamide | 18 Years - | M.D. Anderson Cancer Center | |
| Molecular Triaging of Newly Diagnosed Breast Cancer | NCT01159236 | Breast Cancer | Paclitaxel Fluorouracil Doxorubicin Epirubicin Cyclophosphamid... Bevacizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 | NCT01593020 | Breast Cancer | Paclitaxel Eribulin 5-Fluorouracil Epirubicin Cyclophosphamid... Doxorubicin | 18 Years - | M.D. Anderson Cancer Center | |
| Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients | NCT00038142 | Ewing's Sarcoma | Vincristine Doxorubicin Cyclophosphamid... Dexrazoxane ImmTher | 3 Years - 60 Years | M.D. Anderson Cancer Center | |
| Primary Breast Cancer Occurring Concomitant With Pregnancy | NCT00510367 | Breast Cancer Pregnancy | 5-Fluorouracil Cyclophosphamid... Doxorubicin | - | M.D. Anderson Cancer Center | |
| Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients | NCT00038142 | Ewing's Sarcoma | Vincristine Doxorubicin Cyclophosphamid... Dexrazoxane ImmTher | 3 Years - 60 Years | M.D. Anderson Cancer Center | |
| Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | NCT02419469 | Leukemia Precursor-B Acu... Lymphoblastic L... Lymphoma | Cytarabine Daunorubicin Vincristine Prednisone PEG asparaginas... Ofatumumab Rituximab Methotrexate Cyclophosphamid... Mercaptopurine Doxorubicin Dexamethasone a... Thioguanine | 12 Years - 30 Years | M.D. Anderson Cancer Center | |
| Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases | NCT00080782 | Metastatic Canc... Prostate Cancer | Celecoxib Doxorubicin Hyd... Strontium chlor... | - | M.D. Anderson Cancer Center | |
| Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | NCT02419469 | Leukemia Precursor-B Acu... Lymphoblastic L... Lymphoma | Cytarabine Daunorubicin Vincristine Prednisone PEG asparaginas... Ofatumumab Rituximab Methotrexate Cyclophosphamid... Mercaptopurine Doxorubicin Dexamethasone a... Thioguanine | 12 Years - 30 Years | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
